Cargando…
Immune Phenotyping of Patients With Acute Vogt-Koyanagi-Harada Syndrome Before and After Glucocorticoids Therapy
Previous studies have established that disturbed lymphocytes are involved in the pathogenesis of Vogt-Koyanagi-Harada (VKH) syndrome. Accordingly, glucocorticoids (GCs), with their well-recognized immune-suppressive function, have been widely used for treatment of VKH patients with acute relapses. H...
Autores principales: | Jiang, Han, Li, Zhaohui, Yu, Long, Zhang, Ying, Zhou, Li, Wu, Jianhua, Yuan, Jing, Han, Mengyao, Xu, Tao, He, Junwen, Wang, Shan, Yu, Chengfeng, Pan, Sha, Wu, Min, Liu, Hangyu, Zeng, Haihong, Song, Zhu, Wang, Qiangqiang, Qu, Shen, Zhang, Junwei, Huang, Yafei, Han, Junyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8113950/ https://www.ncbi.nlm.nih.gov/pubmed/33995378 http://dx.doi.org/10.3389/fimmu.2021.659150 |
Ejemplares similares
-
Corrigendum: Immune Phenotyping of Patients With Acute Vogt-Koyanagi-Harada Syndrome Before and After Glucocorticoids Therapy
por: Jiang, Han, et al.
Publicado: (2021) -
Treatment of Vogt-Koyanagi-Harada Disease
por: Alaql, Musab K, et al.
Publicado: (2020) -
Tofacitinib in Vogt-Koyanagi-Harada disease
por: Dutta Majumder, Parthopratim, et al.
Publicado: (2020) -
An Unusual Presentation of Vogt–Koyanagi–Harada
por: Ipek, Sefik Can, et al.
Publicado: (2021) -
Vogt-Koyanagi-Harada Disease and COVID
por: Manni, Priscilla, et al.
Publicado: (2023)